Essilor International (OTCMKTS:ESLOY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Friday, December 1st.
According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “
Separately, Royal Bank of Canada began coverage on Essilor International in a research note on Thursday, September 21st. They issued an “underperform” rating on the stock.
Essilor International (OTCMKTS:ESLOY) opened at $66.22 on Friday. Essilor International has a 52 week low of $53.60 and a 52 week high of $68.43. The company has a quick ratio of 0.76, a current ratio of 1.09 and a debt-to-equity ratio of 0.27.
TRADEMARK VIOLATION WARNING: “Essilor International (OTCMKTS:ESLOY) Upgraded to “Hold” by Zacks Investment Research” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/14/essilor-international-esloy-lifted-to-hold-at-zacks-investment-research.html.
About Essilor International
Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is a France-based ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals.
Get a free copy of the Zacks research report on Essilor International (ESLOY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Essilor International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International and related companies with MarketBeat.com's FREE daily email newsletter.